Double inhibition and activation mechanisms of Ephexin family RhoGEFs
Double inhibition and activation mechanisms of Ephexin family RhoGEFs
复制标题
Ephexin家族RhoGEF的双重抑制和激活机制
DOI:
10.1073/pnas.2024465118
复制
发表时间:
2021-02-23
影响因子:
11.1
通讯作者:
Zhu,Jinwei
中科院分区:
文献类型:
--
作者:
Zhang,Meng;Lin,Lin;Zhu,Jinwei
Significance Ephexin family guanine nucleotide exchange factors (GEFs) act downstream of Eph signaling to regulate cytoskeletal dynamics, playing critical roles in diverse cellular processes. To achieve precise regulation of Eph signaling, the GEF activities of Ephexins need to be tightly controlled. We here present the crystal structures of autoinhibited Ephexin4, which reveal that both N- and C-terminal fragments directly contact with and inhibit the DH catalytic domain of Ephexin4. This double inhibition mechanism may be commonly utilized by other Ephexins and SGEF. Phosphorylation of a conserved tyrosine at its N terminus and association of PDZ protein(s) to its C-terminal PDZ-binding motif may relieve the autoinhibited Ephexin4. These results reveal versatile autoinhibitory mechanisms that fine-tune the GEF activities of Ephexin family RhoGEFs. Ephexin family guanine nucleotide exchange factors (GEFs) transfer signals from Eph tyrosine kinase receptors to Rho GTPases, which play critical roles in diverse cellular processes, as well as cancers and brain disorders. Here, we elucidate the molecular basis underlying inhibition and activation of Ephexin family RhoGEFs. The crystal structures of partially and fully autoinhibited Ephexin4 reveal that the complete autoinhibition requires both N- and C-terminal inhibitory modes, which can operate independently to impede Ras homolog family member G (RhoG) access. This double inhibition mechanism is commonly employed by other Ephexins and SGEF, another RhoGEF for RhoG. Structural, enzymatic, and cell biological analyses show that phosphorylation of a conserved tyrosine residue in its N-terminal inhibitory domain and association of PDZ proteins with its C-terminal PDZ-binding motif may respectively relieve the two autoinhibitory modes in Ephexin4. Our study provides a mechanistic framework for understanding the fine-tuning regulation of Ephexin4 GEF activity and offers possible clues for its pathological dysfunction.